Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240038/S004

FINEVISION HP Trifocal IOLs

Beaver-Visitec International, Inc. · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONP240038/S004

What did the FDA decide?

FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-27 for P240038/S004, a supplement to the FINEVISION HP Trifocal IOLs application held by Beaver Visitec International, Inc. The supplement type is a 30-Day Notice and the recorded reason is a process change affecting manufacturer, sterilizer, packager or supplier. The product is an intraocular lens in the Ophthalmic specialty under product code HQL.

The recorded statement describes a high-throughput optical inspection workflow for routine production of these trifocal intraocular lenses, using existing optical metrology integrated with lens-handling and automated data-processing systems. This entry covers the manufacturing process change only; it is not a new approval of the whole lens system. The source lists no supporting documents, so the inspection specifications, validation data and any effect on finished-device characteristics remain unknown.

Whether the change alters clinical performance or labeling cannot be determined from the available record, and no such conclusion is drawn here.

FDA approval order statement

a high-throughput optical inspection workflow in routine production of FINEVISION HP Trifocal Intraocular Lenses using existing optical metrologer integrated with lens-handling and automated data-processing systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 27, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240038/S004
Regulatory pathway
PMA supplement
Product code
HQL
Decision code
OK30
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

For the original device and its historical approval scope, see PMA P240038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240038 · Original PMA

    FINEVISION HP Trifocal IOLs

  2. P240038/S003 · Related supplement

    FINEVISION HP Trifocal IOLs

  3. P240038/S004 received

    Application receipt date recorded by FDA.

  4. P240038/S004 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P240038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240038

Product / regulatory recordCompanyPathwayDecision dateSource
Beaver-Visitec International, Inc.PMA approvalSep 10, 2025FDA
Beaver-Visitec International, Inc.PMA supplementSep 25, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Beaver-Visitec International, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
500 Totten Pond Rd., Waltham, MA, 02451

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records